The vast potential of non-viral delivery systems of mRNA and pDNA has been demonstrated in the vaccines against coronavirus disease 2019 (COVID-19). Indeed, two formulations of mRNA vaccines from Pfizer–BioNTech and Moderna ...
Apr 15, 2022
0
16
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.
Apr 13, 2022
0
9
Liver cancer is one of the most serious cancers in China. Tumor-initiating cells (TICs), a small subset of cells in the tumor bulk with self-renewal and differentiation capacities, play key roles in tumor formation, metastasis, ...
Apr 8, 2022
0
23
For males and females in all age groups, the risks for cardiac complications are higher after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection than after mRNA COVID-19 vaccination, according to research ...
Apr 7, 2022
0
30
The simple idea of tracking and requiring proof of vaccination created some of the most disruptive protests in Canadian history, and the declaration of a national emergency.
Mar 25, 2022
0
25
mRNA is the key ingredient in COVID-19 vaccines. But what is it, and how does it work? Associate Professor John McGhee and his team at UNSW's 3D Visualisation Aesthetics Lab have created a visually immersive 3D animation ...
Mar 21, 2022
0
0
I don a gown, gloves and a mask to enter the hospital room of a new mother who is sick with COVID-19.
Mar 21, 2022
0
3
Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Mar 16, 2022
0
173
The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna. The study evaluates the safety of and immune responses ...
Mar 14, 2022
0
21
Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture COVID-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) ...
Mar 14, 2022
0
15
